Metronomic decitabine offers a patient-centered frontline therapeutic approach for TP53 -mutated complex-karyotype myeloid neoplasms
Jonathan A. Webster, Lukasz P. Gondek, Mark J. Levis et al.
· 0 citations
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Not available.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.